Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SR510

Introduced
12/14/23  

Caption

A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

Impact

If passed, SR510 would reinforce the FDA's authority in regulating medication abortion by establishing that scientific evaluations of drugs should form the basis of access policies. This could lead to greater consistency in the availability of mifepristone and other medication abortions, potentially countering recent state-level restrictions. Supporters argue that the resolution supports reproductive health equity, particularly in marginalized communities that have been disproportionately affected by restrictions on abortion care.

Summary

SR510 is a resolution expressing the sense of the Senate regarding the scientific judgment of the Food and Drug Administration (FDA) on the safety and efficacy of mifepristone, a medication used for abortion care. The bill asserts that policies governing access to medication abortion should be based on scientific evidence and that the FDA's determinations should not be unduly influenced by other branches of government. This resolution is positioned within a broader context of abortion access in the United States, particularly following restrictions and bans implemented by various states after the Supreme Court's decision to overturn Roe v. Wade.

Contention

The resolution may face opposition from anti-abortion advocates who argue that such medications should not be readily accessible due to moral or safety concerns. Furthermore, there are ongoing debates about the implications of mifepristone's availability, with proponents highlighting the need for equitable access while opponents raise concerns about the ethics of medical abortion. The language crafted in SR510 seeks to navigate these contentious issues by emphasizing the importance of scientific evidence over political interests.

Companion Bills

No companion bills found.

Previously Filed As

US HR309

Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.

US HR0123

A resolution to urge the United States Congress to enact legislation that would ensure abortion is affordable and available for anyone who needs it and to support the President of the United States’ efforts to protect abortion access across the country.

US SCR47

Urging The Members Of Hawaii's Congressional Delegation To Monitor The Alliance For Hippocratic Medicine V. U.s. Food And Drug Administration And Take Action To Limit The Case From Further Restricting Access To Safe Abortion Options.

US SR42

Urging The Members Of Hawaii's Congressional Delegation To Monitor The Alliance For Hippocratic Medicine V. U.s. Food And Drug Administration And Take Action To Limit The Case From Further Restricting Access To Safe Abortion Options.

US HCR6

Urging The Members Of Hawaii's Congressional Delegation To Monitor The Alliance For Hippocratic Medicine V. U.s. Food And Drug Administration And Take Action To Limit The Case From Further Restricting Access To Safe Abortion Options.

US SCR14

Urging The Members Of Hawaii's Congressional Delegation To Monitor The Alliance For Hippocratic Medicine V. U.s. Food And Drug Administration And Take Action To Limit The Case From Further Restricting Access To Safe Abortion Options.

US AR190

Urges United States Supreme Court to protect freedom of reproductive choice with respect to use of and access to mifepristone.

US SR78

Urges United States Supreme Court to protect freedom of reproductive choice with respect to use of and access to mifepristone.

US SR211

A resolution expressing the sense of the Senate that public servants should be commended for their dedication and continued service to the United States during Public Service Recognition Week.

US SR450

A resolution expressing the sense of the Senate that paraprofessionals and education support staff should have fair compensation, benefits, and working conditions.

Similar Bills

CA SB1428

Reproductive health: mifepristone and other medication.

CA AB54

Access to Safe Abortion Care Act.

US HR1285

Condemning the pro-abortion policies of the Biden administration.

NJ SR78

Urges United States Supreme Court to protect freedom of reproductive choice with respect to use of and access to mifepristone.

NJ AR190

Urges United States Supreme Court to protect freedom of reproductive choice with respect to use of and access to mifepristone.

NM HB236

Notice For Medication Abortions

HI HB866

Relating To Health Care.

HI SB1246

Relating To Health Care.